Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Pharmacia & Upjohn OTC management

This article was originally published in The Tan Sheet

Executive Summary

Pharmacia & Upjohn OTC management: Thomas Laughlin named senior VP for Pharmacia & Upjohn Consumer Pharmaceuticals worldwide and general manager of the company's Consumer Pharmaceuticals Center U.S. The Center will manage and develop the U.S. consumer products business, support "sourcing" from the Pharmacia & Upjohn prescription drug U.S. Pharma Product Center and collaborate with the international consumer organization on products originating from the U.S. Laughlin also will join the executive team responsible for worldwide consumer pharmaceuticals, reporting to Pharmacia & Upjohn Consumer Pharmaceuticals President Jorgen Johnsson...

Pharmacia & Upjohn OTC management: Thomas Laughlin named senior VP for Pharmacia & Upjohn Consumer Pharmaceuticals worldwide and general manager of the company's Consumer Pharmaceuticals Center U.S. The Center will manage and develop the U.S. consumer products business, support "sourcing" from the Pharmacia & Upjohn prescription drug U.S. Pharma Product Center and collaborate with the international consumer organization on products originating from the U.S. Laughlin also will join the executive team responsible for worldwide consumer pharmaceuticals, reporting to Pharmacia & Upjohn Consumer Pharmaceuticals President Jorgen Johnsson....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS084583

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel